ID   KF28Tx
AC   CVCL_X936
SY   KF28 TX
DR   CGH-DB; 382-2
DR   Wikidata; Q54899822
RX   PubMed=10741911;
RX   PubMed=18483383;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V533 ! KF28
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 9
//
RX   PubMed=18483383; DOI=10.1158/1078-0432.CCR-07-4358;
RA   Ishibashi, Masako
RA   Nakayama, Kentaro
RA   Yeasmin, Shamima
RA   Katagiri, Atsuko
RA   Iida, Kouji
RA   Nakayama, Naomi
RA   Fukumoto, Manabu
RA   Miyazaki, Kohji
RT   "A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a
RT   potential target for taxol resistance in ovarian cancer.";
RL   Clin. Cancer Res. 14:3149-3155(2008).
//
RX   PubMed=10741911; DOI=10.1007/s004320050027;
RA   Yamamoto, Kenji
RA   Kikuchi, Yoshihiro
RA   Kudoh, Kazuya
RA   Nagata, Ichiro
RT   "Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive
RT   and -resistant human ovarian carcinoma cell lines.";
RL   J. Cancer Res. Clin. Oncol. 126:168-172(2000).
//